The association of serum sodium and chloride levels with blood pressure and estimated glomerular filtration rate

Blood Pressure

Volumn 25, Issue 1, 2016, Pages 51-57

  Nakajima, Kei ^a,b   Oda, Eiji ^c   Kanda, Eiichiro ^d  

^a JOSAI UNIVERSITY   (Japan)

^b Kuki General Hospital   (Japan)

^c Tachikawa Medical Center   (Japan)

^d TOKYO KYOSAI HOSPITAL   (Japan)

Author keywords

Blood pressure; EGFR; kidney function; serum chloride; serum potassium; serum sodium

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHLORIDE; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; SODIUM; TRIACYLGLYCEROL; URIC ACID; MONOVALENT CATION;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; CHLORIDE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; NEPHROTIC SYNDROME; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; AGE; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; BLOOD PRESSURE; CASE-CONTROL STUDIES; CATIONS, MONOVALENT; CHLORIDES; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HEMATOCRIT; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; POTASSIUM; SODIUM;

EID: 84947486776     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2015.1090711     Document Type: Article

References (36)

1. Sliwa K, Stewart S, Gersh BJ. Hypertension: a global perspective. Circulation. 2011;123:2892-6.
2. World Health Organization. World Health Day 2013: calls for intensified efforts to prevent and control hypertension. Available from http://www.who.int/work-forcealliance/media/news/2013/whd2013story/en/index.html
3. Shrivastava SR, Shrivastava PS, Ramasamy J. The determinants and scope of public health interventions to tackle the global problem of hypertension. Int J Prev Med. 2014;5:807-12.
4. Bakris GL, Ritz E; World Kidney Day Steering Committee. The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. J Clin Hypertens (Greenwich). 2009;11:144-7.
5. Sarzani R, Salvi F, Dessì-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens. 2008;26:831-43.
6. Cheung BM, Li C. Diabetes and hypertension: is there a common metabolic pathway? Curr Atheroscler Rep. 2012; 14:160-6.
7. DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol. 2014;10:364-76.
8. de Wardener HE, He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int. 2004;66:2454-66.
9. He FJ, Markandu ND, Sagnella GA, de Wardener HE, MacGregor GA. Plasma sodium: ignored and underestimated. Hypertension. 2005;45:98-102.
10. Safar ME, Temmar M, Kakou A, Lacolley P, Thornton SN. Sodium intake and vascular stiffness in hypertension. Hypertension. 2009;54:203-9.
11. Suckling RJ, Swift PA, He FJ, Markandu ND, MacGregor GA. Altering plasma sodium concentration rapidly changes blood pressure during haemodialysis. Nephrol Dial Transplant. 2013;28:2181-6.
12. Wannamethee G, Whincup PH, Shaper AG, Lever AF. Serum sodium concentration and risk of stroke in middle-aged males. J Hypertens. 1994;12:971-9.
13. Lago RM, Pencina MJ, Wang TJ, Lanier KJ, D'Agostino RB, Kannel WB, Vasan RS. Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study. J Hypertens. 2008;26:2121-5.
14. De Bacquer D, De Backer G, De Buyzere M, Kornitzer M. Is low serum chloride level a risk factor for cardiovascular mortality? J Cardiovasc Risk. 1998;5:177-84.
15. McCallum L, Jeemon P, Hastie CE, et al. Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension. 2013;62:836-43.
16. Kurtz TW, Morris RC. Dietary chloride as a determinant of "sodium-dependent" hypertension. Science. 1983;222: 1139-41.
17. Kurtz TW, Al-Bander HA, Morris RC."Salt-sensitive" essential hypertension in men. Is the sodium ion alone important? N Engl J Med. 1987;317:1043-8.
18. Tanaka M, Schmidlin O, Yi SL, Bollen AW, Morris RC. Genetically determined chloride-sensitive hypertension and stroke. Proc Natl Acad Sci U S A. 1997;94: 14748-52.
19. Kotchen TA. Contributions of sodium and chloride to NaCl-induced hypertension. Hypertension. 2005;45: 849-50.
20. Sowers JR. Recommendations for special populations: diabetes mellitus and the metabolic syndrome. Am J Hypertens. 2003;16:41-55.
21. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-52.
22. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-92.
23. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, et al. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig 2012;3:39-40.
24. Sam R, Feizi I. Understanding hypernatremia. Am J Nephrol. 2012;36:97-104.
25. Oh SW, Baek SH, An JN, Goo HS, Kim S, Na KY, et al. Small increases in plasma sodium are associated with higher risk of mortality in a healthy population. J Korean Med Sci. 2013;28:1034-40.
26. He FJ, Macgregor GA. Salt intake, plasma sodium, and worldwide salt reduction. Ann Med. 2012;44 Suppl 1: S127-37.
27. Oberleithner H, Riethmüller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A. 2007;104:16281-6.
28. Reuter S, Büssemaker E, Hausberg M, Pavenstädt H, Hillebrand U. Effect of excessive salt intake: role of plasma sodium. Curr Hypertens Rep. 2009;11:91-7.
29. Roscioni SS, Heerspink HJ, de Zeeuw D. The effect of RAAS blockade on the progression of diabetic nephro-pathy. Nat Rev Nephrol. 2014;10:77-87.
30. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al.; National Kidney Foundation.National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139: 137-47.
31. Kutsuma A, Nakajima K, Suwa K. Potential association between breakfast skipping and concomitant late-night-dinner eating with metabolic syndrome and proteinuria in the Japanese population. Scientifica (Cairo). 2014;2014: 253581.
32. Jacques T, Picard N, Miller RL, Riemondy KA, Houillier P, Sohet F, et al. Overexpression of pendrin in intercalated cells produces chloride-sensitive hypertension. J Am Soc Nephrol. 2013;24:1104-13.
33. Soleimani M. The multiple roles of pendrin in the kidney. Nephrol Dial Transplant. 2015;30:1257-66.
34. Kawano Y, Minami J, Takishita S, Omae T. Effects of potassium supplementation on office, home, and 24-h blood pressure in patients with essential hypertension. Am J Hypertens. 1998;11:1141-6.
35. Dickinson HO, Nicolson DJ, Campbell F, Beyer FR, Mason J. Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006;(3):CD004641.
36. Drawz PE, Abdalla M, Rahman M. Blood pressure measurement: clinic, home, ambulatory, and beyond. Am J Kidney Dis. 2012;60:449-62.